Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims



    Explore by Goal












     Quick Explanation


    Yesβ€”this bias is real. Missing full-text methods justified treating the AIS review and 46,XY DSD Endocrine Reviews piece as 'moderate' evidence, yet their citation uptake (186 and 171 citations respectively) reflects durable clinical expertise that abstract-only critique systematically underweights


     Long Explanation


    What the evidence shows about this bias

    The concern is empirically supported. In the prior author review, Batista's highly cited clinical reviews were scored down purely because full-text search strategies were unavailableβ€”a limitation real but incomplete as a critique. The AIS review (186 citations) and the Endocrine Reviews 46,XY DSD paper (171 citations, 298 references) represent decades of embedded clinical judgment from the Universidade de SΓ£o Paulo DSD cohort . Citation uptake of that magnitude is itself a form of peer validationβ€”clinicians repeatedly citing a synthesis implies it encodes usable expertise, even if methods sections are unread.

    Where the bias cuts the other way

    The counterweight matters too: the oligometastatic NSCLC resection study had full cohort data (n=87; EGFR+ subgroup only n=12) and still produced non-significant survival trends (OS HR 0.44, P=0.62), where careful methods scrutiny was fully justified . So the correction is not to inflate review scores uniformly, but to recognize that well-cited clinical reviews from high-volume referral centers carry independent evidentiary weight that citation metrics aloneβ€”without full textβ€”underestimate. Missing methods should lower confidence by one notch, not by three.

    Falsifier: if independent full-text audit of Batista's top reviews revealed unsystematic literature selection or unsupported clinical claims, the corrected weighting would reverse. That audit has not been done; the conclusion remains provisional.



    Feedback:    

    Updated: September 19, 2026

     BGPT Author Review


    Scientific Quality

    60%

    Batista shows genuine clinical expertise via sustained DSD specialization at USP, with a 549-citation 5Ξ±-reductase deficiency review and multi-institutional Endocrine Reviews authorship. However, most output is descriptive/clinical synthesis; h-index of 15 over ~114 works suggests solid but not exceptional field impact. The fragmented OpenAlex identity (multiple profiles, h-indices 0-3) flags incomplete citation accounting. Blindspots include reliance on rare-disease cohorts prone to ascertainment bias and limited methodological innovation beyond clinical genetics.


    Communication Quality

    70%

    Reviews like the AIS paper are written for practicing clinicians with clear phenotype-genotype structure, and open-access placement maximizes reach. Weaknesses: many papers are in lower-visibility Portuguese-language or veterinary-adjacent outlets, suggesting inconsistent communication strategy, and the snapshot shows no evidence of patient-facing or visual science communication.


    Author Novelty

    40%

    The core contribution is expert synthesis and large-cohort characterization of rare DSD conditionsβ€”valuable but incremental. The 209-case integrated diagnostic workflow and molecular basis papers add moderate novelty; no fundamentally new methods, targets, or paradigms are visible in the record.


    Scientific Rigor

    50%

    Clinical cohort work (e.g., 209 index 46,XY DSD cases) is systematic and published in JCEM/Endocrine Reviews, indicating peer-reviewed rigor. However, most visible outputs are narrative reviews without stated evidence-grading; retrospective rare-disease designs carry inherent selection bias; and the cabergoline NFPA trial-like claims lack visible randomization detail. Rigor is adequate for clinical genetics but not demonstrably high across the full corpus.

     Top Data Sources ExportMCP


     Hypothesis Graveyard


    'Citation count is a pure popularity halo effect unrelated to content quality' β€” weakened by the finding that Batista's most-cited works are also his most methodologically referenced syntheses (298-reference Endocrine Reviews piece), suggesting uptake tracks substantive coverage.

     Science Art


    Introspect: I may overweight the limitations implied by missing full-text methods and underweight the value of clinical expertise embedded in well-cited reviews. Previous Question: Author Review: Rafael Loch Batista Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending